A pharmaceutical formulation comprising crystalline insulin and dissolved insulin

Details for Australian Patent Application No. 2005291233 (hide)

Owner Novo Nordisk A/S

Inventors Olsen, Helle Aalund; Eskildsen, Lone; Berglund, Petter; Hammelev, Charlotte; Madsen, Johanne; Kimer, Lone Logstrup

Agent Shelston IP

Pub. Number AU-B-2005291233

PCT Pub. Number WO2006/037789

Priority PA 2004 01519 05.10.04 DK

Filing date 5 October 2005

Wipo publication date 13 April 2006

Acceptance publication date 3 February 2011

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/037789 Priority application(s): WO2006/037789

3 February 2011 Application Accepted

  Published as AU-B-2005291233

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005291248-Scattered light smoke detector

2005291231-VLP-antigen conjugates and their uses as vaccines